News
Over the last year, a CT man and his wife have driven to Waterbury to make art with others living with early-stage ...
8d
CT Insider on MSNHow one program brings art, connection to those facing Alzheimer’s in CTLongtime Shelton resident Mike Quirk has always loved the arts and the museums that showcase them. A water and acrylic painter by nature and a retired graphic designer, Quirk said art is a good way to ...
Jim Parkinson, the designer behind Rolling Stone's iconic logo, has died at 83 after a long battle with Alzheimer’s, his friend confirmed.
The show is the culmination of a yearlong collaboration that welcomes individuals with early stage dementia and their loved ...
Parse Biosciences today announced their commitment to support researchers from the Icahn School of Medicine at Mount Sinai in generating one of the largest single cell datasets focused on ...
Alzheimer’s Care Armenia is pleased to announce the launch of the Support Café for Artsakh Elders, a new initiative designed ...
The Long Island Museum, 1200 Route 25A, Stony Brook will host the 9th Annual Arts & Alzheimer’s Conference on Thursday, June 26 from 9:30 a.m. to 3 p.m.
Alzheimer’s disease and other forms of dementia are medical conditions that target areas of the brain that control memory and behavior. While no singular cure has been established, therapeutic ...
In Alzheimer’s disease, often the first type of memory to be affected is episodic memory. Those are the memories that help you recall specific moments in your life.
Painting, drawing, and other forms of art therapy can help people with Alzheimer’s disease express themselves. Expression through art can become especially important as a person’s ability to ...
Hosted on MSN2mon
Memories in the Making | Alzheimer’s Association - MSNArt is a powerful thing that can provoke and inspire people, but for those living with Alzheimer’s Disease, it's the only way they can express themselves. That's why one organization is ...
Gilbert, who is chatty and eager to laugh, was diagnosed with Alzheimer’s disease in late 2023, soon after lecanemab, a new therapy designed to slow the disease’s progress, became available.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results